Medifast (MED) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $12.06, +1.77% vs the prior close of $11.85.
- Volume 119.40K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MED rises 1.8% to $12.06, 5 up days in a row. Closed at $12.06, +1.77% vs the prior close of $11.85. Day range $11.90–$12.37, opened at $11.91.
MED daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MED rises 1.8% to $12.06, 5 up days in a row
- Closed at $12.06, +1.77% vs the prior close of $11.85. Day range $11.90–$12.37, opened at $11.91.
- Volume was 119.40K shares, 1.0x its 50-day average of 123.68K.
- Price is +1.3% vs its 50-day average ($11.90) and +7.1% vs its 200-day average ($11.26).
- 52-week range $9.22–$13.58; today's close sits at 65% of that range, 11.2% below the 52-week high.
- That makes 5 straight gains.
Oct 14, 2026 — MED rises 1.5% to $11.85, 4 up days in a row
- Closed at $11.85, +1.54% vs the prior close of $11.67. Day range $11.57–$11.87, opened at $11.67.
- Volume was 197.00K shares, 1.4x its 50-day average of 137.91K.
- Price is -0.5% vs its 50-day average ($11.90) and +5.3% vs its 200-day average ($11.25).
- 52-week range $9.22–$13.58; today's close sits at 60% of that range, 12.7% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — MED rises 0.4% to $11.67, 3 up days in a row
- Closed at $11.67, +0.43% vs the prior close of $11.62. Day range $11.51–$11.79, opened at $11.60.
- Volume was 102.80K shares, 0.7x its 50-day average of 140.87K.
- Price is -2.2% vs its 50-day average ($11.93) and +3.8% vs its 200-day average ($11.25).
- 52-week range $9.22–$13.60; today's close sits at 56% of that range, 14.2% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — MED ends flat (+0.1%) to $11.62
- Closed at $11.62, +0.09% vs the prior close of $11.61. Day range $11.54–$11.76, opened at $11.64.
- Volume was 91.70K shares, 0.6x its 50-day average of 141.10K.
- Price is -2.3% vs its 50-day average ($11.89) and +3.3% vs its 200-day average ($11.25).
- 52-week range $9.22–$14.06; today's close sits at 50% of that range, 17.4% below the 52-week high.
Oct 9, 2026 — MED rises 1.6% to $11.61
- Closed at $11.61, +1.57% vs the prior close of $11.43. Day range $11.42–$11.64, opened at $11.51.
- Volume was 58.40K shares, 0.4x its 50-day average of 142.34K — lighter than usual.
- Price is -2.1% vs its 50-day average ($11.85) and +3.3% vs its 200-day average ($11.24).
- 52-week range $9.22–$14.15; today's close sits at 48% of that range, 18.0% below the 52-week high.
Oct 8, 2026 — MED ends flat (-0.1%) to $11.43, 4 down days in a row
- Closed at $11.43, -0.09% vs the prior close of $11.44. Day range $11.38–$11.53, opened at $11.45.
- Volume was 110.60K shares, 0.8x its 50-day average of 142.70K.
- Price is -3.3% vs its 50-day average ($11.82) and +1.7% vs its 200-day average ($11.24).
- 52-week range $9.22–$14.15; today's close sits at 45% of that range, 19.2% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — MED dips 0.6% to $11.44, 3 down days in a row
- Closed at $11.44, -0.61% vs the prior close of $11.51. Day range $11.39–$11.61, opened at $11.39.
- Volume was 84.20K shares, 0.6x its 50-day average of 142.98K — lighter than usual.
- Price is -2.9% vs its 50-day average ($11.78) and +1.7% vs its 200-day average ($11.24).
- 52-week range $9.22–$14.15; today's close sits at 45% of that range, 19.2% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — MED dips 1.4% to $11.51
- Closed at $11.51, -1.37% vs the prior close of $11.67. Day range $11.51–$11.86, opened at $11.71.
- Volume was 84.70K shares, 0.6x its 50-day average of 144.33K — lighter than usual.
- Price is -2.0% vs its 50-day average ($11.75) and +2.3% vs its 200-day average ($11.25).
- 52-week range $9.22–$14.15; today's close sits at 46% of that range, 18.7% below the 52-week high.
Oct 5, 2026 — MED dips 0.5% to $11.67
- Closed at $11.67, -0.51% vs the prior close of $11.73. Day range $11.62–$11.78, opened at $11.69.
- Volume was 65.80K shares, 0.4x its 50-day average of 147.17K — lighter than usual.
- Price is -0.4% vs its 50-day average ($11.72) and +3.7% vs its 200-day average ($11.25).
- 52-week range $9.22–$14.15; today's close sits at 50% of that range, 17.5% below the 52-week high.
Oct 2, 2026 — MED rises 2.6% to $11.73
- Closed at $11.73, +2.62% vs the prior close of $11.43. Day range $11.54–$11.75, opened at $11.56.
- Volume was 82.60K shares, 0.5x its 50-day average of 150.77K — lighter than usual.
- Price is +0.4% vs its 50-day average ($11.68) and +4.2% vs its 200-day average ($11.25).
- 52-week range $9.22–$14.15; today's close sits at 51% of that range, 17.1% below the 52-week high.
MED latest news & SEC filings
Every SEC filing by or about MED in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chard Daniel R sold 9,545 shares at $11.98 (≈$114.34K) on Sep 28, 2026; now holds 140,153
- Chard Daniel R sold 9,544 shares at $11.73 (≈$111.95K) on Sep 29, 2026; now holds 130,609
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 28, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kiai Parsa bought 41,975 shares at $12.26 (≈$514.61K) on Aug 26, 2026
- Kiai Parsa bought 1,175 shares at $12.26 (≈$14.41K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kiai Parsa bought 4,211 shares at $12.00 (≈$50.53K) on Aug 24, 2026
- Kiai Parsa bought 118 shares at $12.00 (≈$1.42K) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kiai Parsa bought 41,975 shares at $11.60 (≈$486.91K) on Aug 20, 2026
- Kiai Parsa bought 1,175 shares at $11.60 (≈$13.63K) on Aug 20, 2026
- Kiai Parsa bought 799 shares at $11.66 (≈$9.32K) on Aug 19, 2026
- Kiai Parsa bought 28,538 shares at $11.66 (≈$332.75K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $76.38M (prior year $105.56M) (-27.6% vs Jun 30, 2025)
- Net income: -$3.10M (prior year $2.48M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.28 (prior year $0.22) (loss widened vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade MED
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 17, 2026, Nov 3, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.37% (largest 4.2%).
- Liquidity: about 125.90K shares (≈$1.52M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $12.06 vs a range of $9.22–$13.58 (65% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 11 open-market buys, 2 sales; latest: Daniel R Chard sold 9,544 shares on Sep 29, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jul 17, 2026.
- Share count: 11.18M shares outstanding (Jul 27, 2026), +1.7% vs a year earlier.
- Listing: NYSE · industry: Miscellaneous Food Preparations & Kindred Products.
MED market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 11.91 | 12.37 | 11.90 | 12.06 | 119.40K |
| Oct 14, 2026 | 11.67 | 11.87 | 11.57 | 11.85 | 197.00K |
| Oct 13, 2026 | 11.60 | 11.79 | 11.51 | 11.67 | 102.80K |
| Oct 12, 2026 | 11.64 | 11.76 | 11.54 | 11.62 | 91.70K |
| Oct 9, 2026 | 11.51 | 11.64 | 11.42 | 11.61 | 58.40K |
| Oct 8, 2026 | 11.45 | 11.53 | 11.38 | 11.43 | 110.60K |
| Oct 7, 2026 | 11.39 | 11.61 | 11.39 | 11.44 | 84.20K |
| Oct 6, 2026 | 11.71 | 11.86 | 11.51 | 11.51 | 84.70K |
| Oct 5, 2026 | 11.69 | 11.78 | 11.62 | 11.67 | 65.80K |
| Oct 2, 2026 | 11.56 | 11.75 | 11.54 | 11.73 | 82.60K |
| Oct 1, 2026 | 11.44 | 11.67 | 11.30 | 11.43 | 123.20K |
| Sep 30, 2026 | 11.68 | 11.72 | 11.51 | 11.52 | 138.10K |
| Sep 29, 2026 | 11.77 | 11.79 | 11.60 | 11.61 | 124.00K |
| Sep 28, 2026 | 12.05 | 12.13 | 11.71 | 11.71 | 113.00K |
| Sep 25, 2026 | 11.89 | 12.31 | 11.83 | 12.17 | 200.40K |
| Sep 24, 2026 | 11.91 | 12.02 | 11.75 | 11.92 | 78.50K |
| Sep 23, 2026 | 12.04 | 12.18 | 11.86 | 11.95 | 113.90K |
| Sep 22, 2026 | 12.38 | 12.48 | 12.08 | 12.08 | 72.60K |
| Sep 21, 2026 | 11.82 | 12.34 | 11.82 | 12.26 | 158.10K |
| Sep 18, 2026 | 11.94 | 12.05 | 11.73 | 11.77 | 399.00K |
About Medifast
Medifast (MED) is listed on the NYSE and classified by the SEC under “Miscellaneous Food Preparations & Kindred Products”. Its business address is in BALTIMORE, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 910329.
MED board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel R Chard | Director | Sep 30, 2026 |
| Elizabeth A. Geary | Director | May 28, 2026 |
| Parsa Kiai | Director | Aug 28, 2026 |
| Jeffrey Matthew Rose | Director | May 28, 2026 |
| Scott Schlackman | Director | May 28, 2026 |
| Andrea B Thomas | Director | May 28, 2026 |
| Ming Xian | Director | May 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nicholas Mark Johnson | President | Mar 27, 2026 |
| Jonathan Barrett Mackenzie | VP, Finance & CAO | Mar 27, 2026 |
| James P. Maloney | Chief Financial Officer | Mar 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Daniel R Chard | Sale | 9,544 | $11.73 |
| Sep 28, 2026 | Daniel R Chard | Sale | 9,545 | $11.98 |
| Aug 26, 2026 | Parsa Kiai | Buy | 41,975 | $12.26 |
| Aug 26, 2026 | Parsa Kiai | Buy | 1,175 | $12.26 |
| Aug 24, 2026 | Parsa Kiai | Buy | 4,211 | $12.00 |
| Aug 24, 2026 | Parsa Kiai | Buy | 118 | $12.00 |
| Aug 20, 2026 | Parsa Kiai | Buy | 41,975 | $11.60 |
| Aug 20, 2026 | Parsa Kiai | Buy | 1,175 | $11.60 |
| Aug 19, 2026 | Parsa Kiai | Buy | 799 | $11.66 |
| Aug 19, 2026 | Parsa Kiai | Buy | 28,538 | $11.66 |
| May 11, 2026 | Scott Schlackman | Buy | 2,500 | $12.53 |
| May 8, 2026 | Scott Schlackman | Buy | 2,500 | $12.65 |
| Mar 20, 2026 | Daniel R Chard | Buy | 17,678 | $10.11 |
MED financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $385.79M | $-18.67M | -1.70 | $6.86M |
| Dec 31, 2024 | $602.46M | $2.09M | 0.19 | $24.48M |
| Dec 31, 2023 | $1.07B | $99.42M | 9.10 | $147.66M |
| Dec 31, 2022 | $1.60B | $143.57M | 12.73 | $194.57M |
| Dec 31, 2021 | $1.53B | $164.03M | 13.89 | $94.55M |
Latest balance sheet: total assets $260.40M, total liabilities $64.02M, cash $71.91M (as of Jun 30, 2026).
MED earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $9.74 |
| May 4, 2026 | 8-K Item 2.02 (results) | $10.63 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $10.80 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $11.88 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $13.51 |
| Apr 28, 2025 | 8-K Item 2.02 (results) | $12.58 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $16.13 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $18.81 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| Apr 29, 2024 | 8-K Item 2.02 (results) | — |
| Feb 20, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Miscellaneous Food Preparations & Kindred Products
Mccormick (MKC)Utz Brands (UTZ)Top Wealth (TWG)Coffee (JVA)Mccormick (MKC-V)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MED
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.